Residual red blood cells in liquid plasma products: A quality assessment.

Journal: American journal of clinical pathology
Published Date: May 10, 2025

Abstract

OBJECTIVES: Liquid plasma (LP) is an increasingly utilized blood product due to its immediate availability for transfusion without requiring thawing. While concerns exist regarding the presence of intact residual red blood cells (RBCs) in plasma products that have never been frozen, limited data are available on their levels in LP. This study aimed to evaluate residual RBC content in LP products to assess their safety for transfusion.

Authors

  • Furkan Yigitbilek
    Department of Pathology, Stanford University School of Medicine, Stanford, CA, United States.
  • Suchitra Pandey
    Department of Pathology, Stanford University School of Medicine, Stanford, CA, United States.
  • Tho Pham
    Department of Pathology, Stanford University School of Medicine, Stanford, CA, United States.
  • Mrigender Singh Virk
    Department of Pathology, Stanford University School of Medicine, Stanford, CA, United States.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals